Variable increase | Antipsychotic-naïve group | Previous antipsychotic-use group | Z | P | ES |
---|---|---|---|---|---|
Weight (kg) | |||||
Week 4 | 2.84±3.35 | 1.59±2.49 | 3.29 | <0.001 | 0.297 |
Week 6 | 4.24±3.90 | 2.22±3.35 | 4.53 | <0.001 | 0.296 |
BMI (kg/m2) | |||||
Week 4 | 0.73±1.76 | 0.28±0.67 | 2.83 | 0.005 | 0.298 |
Week 6 | 1.77±2.37 | 1.30±0.88 | 4.31 | <0.001 | 0.296 |
Cholesterol (mmol l−1) | |||||
Week 4 | 0.15±1.35 | 0.31±1.19 | -0.96 | 0.338 | 0.302 |
Week 6 | 0.45±0.91 | 0.35±0.92 | 0.86 | 0.391 | 0.300 |
Triglyceride (mmol l−1) | |||||
Week 4 | 0.59±1.08 | 0.71±0.92 | 0.02 | 0.984 | 0.301 |
Week 6 | 0.68±0.65 | 0.61±1.10 | 0.70 | 0.486 | 0.300 |
HDL-C (mmol l−1) | |||||
Week 4 | -0.11±0.44 | -0.04±0.55 | -0.90 | 0.369 | 0.302 |
Week 6 | 0.00±0.41 | -0.03±0.33 | 0.26 | 0.435 | 0.301 |
LDL-C (mmol l−1) | |||||
Week 4 | 0.06 ±0.85 | 0.30±0.81 | -2.19 | 0.030 | 0.303 |
Week 6 | 0.23±0.67 | 0.56±0.75 | -3.89 | <0.001 | 0.306 |
Fasting glucose (mmol l−1) | |||||
Week 4 | -0.13±1.06 | 0.00±1.03 | -0.92 | 0.358 | 0.302 |
Week 6 | 0.20±0.74 | 0.04±0.81 | 1.67 | 0.096 | 0.299 |